The Commerce Department and the International Trade Commission released notices Dec. 1 on its initiation of two months' worth of sunset reviews, including one month of reviews that actually began Nov. 3 but that weren't announced because of the recently ended federal government shutdown.
Sen. Tom Cotton, R-Ark., asked the U.S. attorney general and Homeland Security Investigations "to prioritize Shein and Temu facilities for immediate inspections, seizures, and criminal investigations" over their counterfeits and intellectual property theft.
Following the Supreme Court's oral argument in the lead cases on whether the president can use the International Emergency Economic Powers Act to impose tariffs, various trade lawyers speculated that the high court now appears poised to strike down the tariffs.
Electronics importer Harman International Industries agreed to pay more than $11.8 million to settle allegations it evaded antidumping and countervailing duties on aluminum extrusions from China, the U.S. Attorney's Office for the Eastern District of Michigan announced on Nov. 26.
CBP issued the following releases on commercial trade and related matters:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Nov. 28, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP reminded the trade that the annual user fee that customs brokers must pay is due by Jan. 30, according to a Federal Register notice. The fee for calendar year 2026 will be $185.38, according to CBP.
CBP is informing the Office of Management and Budget that it is revising instructions for Form 7501, which is used for entry summary filing, to clarify what defines country of melt and pour for steel imports and what defines country of smelted and cast for aluminum imports, according to a Federal Register notice.
Since the United Kingdom's National Health Service has agreed to pay more for new medicines, the Trump administration is pledging "to exempt U.K.-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from Section 232 tariffs and will refrain from targeting U.K. pharmaceutical pricing practices in any future Section 301 investigation for the duration of President [Donald] Trump’s term."
Law firms are advising clients of changes to Mexican customs laws that begin Jan. 1, including that customs brokers will be liable if their clients provide false or inaccurate information.